Related Experiment Video
Updated: Mar 29, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Gregory J Baker1, Maria G Castro1, Pedro R Lowenstein2
1Department of Neurosurgery, University of Michigan; Department of Cell and Developmental Biology, University of Michigan.
Abstract:
Our laboratory has recently demonstrated that natural killer (NK) cells are capable of eradicating orthotopically implanted mouse GL26 and rat CNS-1 malignant gliomas soon after intracranial engraftment if the cancer cells are rendered deficient in their expression of the β-galactoside-binding lectin galectin-1 (gal-1). More recent work now shows that a population of Gr-1+/CD11b+ myeloid cells is critical to this effect. To better understand the mechanisms by which NK and myeloid cells cooperate to confer gal-1-deficient tumor rejection we have developed a comprehensive protocol for the isolation and analysis of glioma-infiltrating peripheral blood mononuclear cells (PBMC). The method is demonstrated here by comparing PBMC infiltration into the tumor microenvironment of gal-1-expressing GL26 gliomas with those rendered gal-1-deficient via shRNA knockdown. The protocol begins with a description of how to culture and prepare GL26 cells for inoculation into the syngeneic C57BL/6J mouse brain. It then explains the steps involved in the isolation and flow cytometric analysis of glioma-infiltrating PBMCs from the early brain tumor microenvironment. The method is adaptable to a number of in vivo experimental designs in which temporal data on immune infiltration into the brain is required. The method is sensitive and highly reproducible, as glioma-infiltrating PBMCs can be isolated from intracranial tumors as soon as 24 hr post-tumor engraftment with similar cell counts observed from time point matched tumors throughout independent experiments. A single experimentalist can perform the method from brain harvesting to flow cytometric analysis of glioma-infiltrating PBMCs in roughly 4-6 hr depending on the number of samples to be analyzed. Alternative glioma models and/or cell-specific detection antibodies may also be used at the experimentalists' discretion to assess the infiltration of several other immune cell types of interest without the need for alterations to the overall procedure.
Insights
Natural killer (NK) cells and myeloid cells cooperate to reject gliomas lacking galectin-1 (gal-1). This study details a protocol for analyzing immune cell infiltration in the brain tumor microenvironment, crucial for understanding this rejection mechanism.
Area of Science:
- Immunology
- Neuro-oncology
- Cell Biology
Background:
- Malignant gliomas are aggressive brain tumors with poor prognoses.
- Natural killer (NK) cells and myeloid cells play roles in anti-tumor immunity.
- Galectin-1 (gal-1) expression in glioma cells influences their susceptibility to immune attack.
Purpose of the Study:
- To develop and validate a comprehensive protocol for isolating and analyzing glioma-infiltrating peripheral blood mononuclear cells (PBMCs).
- To investigate the cooperative mechanisms between NK cells and myeloid cells in galectin-1-deficient glioma rejection.
- To compare immune cell infiltration in galectin-1-expressing versus galectin-1-deficient gliomas.
Main Methods:
- Culturing and preparing GL26 glioma cells for intracranial inoculation in C57BL/6J mice.
- Isolation of glioma-infiltrating PBMCs from the brain tumor microenvironment at early time points post-engraftment.
- Flow cytometric analysis of isolated PBMCs to quantify immune cell populations.
Main Results:
- The protocol enables sensitive and reproducible isolation of glioma-infiltrating PBMCs as early as 24 hours post-engraftment.
- Consistent cell counts were observed across independent experiments and time points.
- The method effectively differentiates PBMC infiltration between galectin-1-expressing and galectin-1-deficient gliomas.
Conclusions:
- The developed protocol is a valuable tool for studying immune cell dynamics in the brain tumor microenvironment.
- This method facilitates the investigation of NK and myeloid cell cooperation in glioma rejection.
- The protocol is adaptable for analyzing various immune cell types in different glioma models.

